CTF in the NewsFeaturedFeatured EUScience & Research PharmaPhorum Interview: How Drug Repositioning is Accelerating Treatments for NF Patients
FeaturedFeatured EUNF1PharmaPress Release FDA Grants Priority Review to SpringWorks Therapeutics’ New Drug for NF1 Patients
FeaturedNF1Patient EngagementScience & Research Summary Report from NF Patients’ Testimony to FDA about living with cutaneous neurofibromas
FeaturedGlobalNF ConferencePress ReleaseScience & ResearchTop Story EU Children’s Tumor Foundation Europe Leads Collective Effort in Accelerating Therapeutics and Innovation for Rare Diseases
FeaturedNF1Patient Engagement Natural History Study of Cutaneous Neurofibromas in People with Neurofibromatosis Type 1 (NF1)
AwarenessFeaturedFeatured EUPress Release Global Landmarks Illuminate for World NF Awareness Day as Children’s Tumor Foundation Highlights its Make NF Research Visible Campaign
